Skip to main content
Menu
US
US

Resource Center

Filters
Select resource types
Select products & services (2)
Select solutions
Active Filters (2)
Clear All
1 - 12 of 73 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Brochure Icon   Brochure
Vanadis NIPT system
Outlines differentiating features of the Vanadis NIPT system, inclusive of minimal hands-on time, walkaway automation, high precision and no PCR or sequencing. Empowering any laboratory to conduct NIPT in-house.
Brochure Icon   Brochure
Vanadis cfDNA platform
Highlights the defining features behind the Vanadis cfDNA platform, including its ease of use, full automation, high precision and no PCR or sequencing required. Now any lab can conduct cfDNA analysis in-house.
Whitepaper Icon   Whitepaper
Addressing the challenges of bispecific antibody characterization with high-throughput platforms
With the complexities of bispecific antibody development and characterization explore the binding assays and technology through real-world examples
Whitepaper Icon   Whitepaper
Murine NASH model could provide insights into NASH development and progression
Researchers explore a multidisciplinary approach to addressing current NAFLD and NASH challenges.
Infographic Icon   Infographic
The impact of no-call rate in NIPT
A reference that highlights the clinical importance of no-call rate in NIPT (non-invasive prenatal testing).
Technical Note Icon   Technical Note
AlphaLISA Acetyl‑Histone H3 lysine 9 (H3K9ac) cellular assay
This technical note provides information on how the AlphaLISA immunodetection assay detects variations in acetylated histone H3 lysine 9 (H3K9ac) levels within cellular extracts
Technical Note Icon   Technical Note
Assessing AST released in a cell culture model of liver toxicity using AlphaLISA
In this technical note, we showcase the utility and advantages of using AlphaLISA assays to identify and quantify AST protein levels in cellular lysate and supernatant from a human hepatoma cell line
Technical Note Icon   Technical Note
AlphaLISA for biomarkers in urine: Measuring the renal tubular injury indicator, β2-microglobulin
In this study, AlphaLISA™ technology is demonstrated for the first time in the complex matrix of urine, and is shown to detect the renal tubular injury marker Beta2-microglobulin (β2-microglobulin), in urine at a sensitivity
Article Icon   Article
Busting high-content imaging myths
High-content imaging has become a cornerstone of life science research, providing valuable insights into cellular function and drug responses. However, as with any advanced technology, misconceptions and myths can emerge. In this article, we’ll debunk some of the most common myths surrounding high-content imaging, shedding light on its true strengths and limitations.
Publication Icon   Literature - Publication Review
Inhibiting interleukin 11 signaling reduces and reverses many dangerous effects of NAFLD/NASH in mouse models
Study demonstrating that inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of NASH
eBook Icon   eBook
Upscaling organoid research for sharper biological insights
To scale up, standardize and achieve greater biological insights, researchers need to rely on automation and multi-dimensional datasets.
Technical Note Icon   Technical Note
Designing your own AlphaLISA assay: Selecting toolbox bead pairs to avoid potential bead-bead interactions
This technical note provides recommendations on bead pairings, highlighting host species of antibodies on each toolbox bead, along with data generated in the absence of analyte and other assay components.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.